Company data sheet · CVS Health
CVS Health: three decisions on record.
- Industry
- Drug Stores and Proprietary Stores
- Headquarters
- United States
- Ticker
- CVS (NYSE)
- Sources
- SEC filings (1994–2026), Stratrix's verified Decision Cases, market data and official economic statistics for the United States
- Data as of
- November 1, 2026
- Three decisions on record. Stratrix has verified three of CVS Health's big decisions, each with what happened next. The hardest year after: "Everyone Blames the Opioid Settlement. CVS Decided to Close the Stores a Year Earlier", with its shares 65 points behind the S&P 500 over the next three years.
Financial results
| Fiscal year | Revenue | Net income | |
|---|---|---|---|
| 2016 | $178 billion | $5.3 billion | |
| 2017 | $185 billion | $6.6 billion | |
| 2018 | $195 billion | −$0.6 billion | |
| 2019 | $257 billion | $6.6 billion | |
| 2020 | $269 billion | $7.2 billion | |
| 2021 | $292 billion | $8 billion | |
| 2022 | $322 billion | $4.3 billion | |
| 2023 | $358 billion | $8.3 billion | |
| 2024 | $373 billion | $4.6 billion | |
| 2025 | $402 billion | $1.8 billion |
As reported in its annual filings. Losses in red.
Stratrix Decision Cases
The full data sheet · Data Plan
Everything behind these findings, ready for your board deck.
- Market reaction to disclosed decisions: 40 decision filings since 2016, each linked to the SEC, with the share return against its sector and the US market the next day and the next year (32 with market data).
- Economic context: 7 measures for the United States, every year since 2016, from the official sources.
- Peer comparison: against 71 companies of its size in its sector.
- Financial results: ten years of revenue, operating and net income, and every annual report, linked.
- Methods and sources, so each number can be checked and cited.
The full data sheet downloads with the Data Plan. To see exactly what you get first, open the Boeing sample PDF or Excel.